Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Up – Time to Buy?

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) gapped up before the market opened on Tuesday . The stock had previously closed at $24.69, but opened at $26.23. Kestra Medical Technologies shares last traded at $25.42, with a volume of 32,975 shares trading hands.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on KMTS. BTIG Research assumed coverage on shares of Kestra Medical Technologies in a report on Tuesday, November 18th. They set a “buy” rating and a $32.00 price target on the stock. Weiss Ratings restated a “sell (d)” rating on shares of Kestra Medical Technologies in a report on Wednesday, October 8th. Finally, Wall Street Zen lowered shares of Kestra Medical Technologies from a “hold” rating to a “sell” rating in a research report on Sunday, September 28th. Six analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $28.00.

Kestra Medical Technologies Stock Down 5.1%

The stock has a market capitalization of $1.26 billion and a PE ratio of -9.61. The business has a 50 day moving average of $25.45 and a two-hundred day moving average of $20.72. The company has a debt-to-equity ratio of 0.23, a quick ratio of 6.84 and a current ratio of 6.84.

Kestra Medical Technologies (NASDAQ:KMTS) last posted its earnings results on Thursday, September 11th. The company reported ($0.50) EPS for the quarter, beating analysts’ consensus estimates of ($0.66) by $0.16. The firm had revenue of $19.37 million for the quarter, compared to analysts’ expectations of $17.68 million.

Hedge Funds Weigh In On Kestra Medical Technologies

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Quarry LP purchased a new stake in Kestra Medical Technologies during the 1st quarter valued at about $33,000. China Universal Asset Management Co. Ltd. purchased a new position in Kestra Medical Technologies during the 3rd quarter worth approximately $48,000. Police & Firemen s Retirement System of New Jersey purchased a new stake in shares of Kestra Medical Technologies in the 2nd quarter valued at $54,000. BNP Paribas Financial Markets lifted its position in Kestra Medical Technologies by 148.9% during the third quarter. BNP Paribas Financial Markets now owns 2,738 shares of the company’s stock valued at $65,000 after purchasing an additional 1,638 shares during the period. Finally, Brown Brothers Harriman & Co. raised its stake in shares of Kestra Medical Technologies by 26.8% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 3,104 shares of the company’s stock valued at $74,000 after buying an additional 656 shares during the last quarter.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.